IPHA ‘Manifesto’ Issues Call To Place Ireland in Top Seven in Europe For Access To New Medicines

Pharmaceutical innovators’ new declaration of strategic priorities urges:

§  Predictable, multi-annual budgeting for innovative medicines, with sustained rise in funding

§  ‘Innovation czar’ for Department of Health to plan for the global wave of pharmaceutical research

§  New era of industry-Government partnership to avert deepening healthcare crisis

 

Read more

New President at IPHA

Aidan Lynch, Vice President and General Manager of GSK (Ireland) Limited, has been elected as President of the Irish Pharmaceutical Healthcare Association (IPHA).

Read more

New Report Backs Biopharma Innovation as Enabler for New Treatments, Jobs and Investments, says IPHA

Protecting Ireland’s innovation policy environment is key to developing new medicines for patients, and to attracting fresh investments in pharmaceutical manufacturing and research, according to a report published today [Friday] by EY-DKM, the economic advisory consultants. 

Read more

NEW IPHA DATA SHOWS IRISH PATIENTS DENIED ACCESS TO VITAL CANCER MEDICINES

Irish patients are among the last in western Europe to have access to vital cancer medicines, placing at risk the Government’s target to put Ireland in the top quartile of European countries for cancer survival within the next decade.

 

Read more

Biopharma Industry’s Latest Price Drops Save €15m on Government’s Medicines Bill, says IPHA

Ireland’s research-based pharmaceutical industry is set to save the Government €15 million on medicines by introducing price reductions today [Sunday] for more than 750 packs of innovative medicines

Read more

IPHA Urges Progress on Access to Medicines as Ireland Signs Up to BeNeLuxA

As Ireland signed up today [Friday] to the BeNeLuxA Initiative on pricing and supply of innovative medicines, the Irish Pharmaceutical Healthcare Association (IPHA) has said the focus of policymakers and industry must remain on fixing a slow and inefficient medicines approvals process for Irish patients

Read more

Focus must remain on biopharma innovation as European Commission proposes new IP laws, says IPHA

The Irish Pharmaceutical Healthcare Association (IPHA), which represents the research-based pharmaceutical industry in Ireland, has said a continued focus on innovation is key to unlocking the potential of new medicines to improve healthcare outcomes and attract investments in the future.

Read more